Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript

·41-min read
Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript

At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Good morning, and thank you for joining us today for a general business update and to review the financial results of Myovant's fourth quarter of fiscal year 2020. Joining me for today's call are Dave Marek, Myovant's chief executive officer; Frank Karbe, president and chief financial officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer.